More compelling evidence on why circumcision should be routine

March 25, 2009

New data from Ugandan scientists and investigators at Johns Hopkins University find that adult male circumcision decreased rates of the two most common sexually transmitted infections - herpes and the human papillomavirus (HPV), the virus that causes cervical cancer and genital warts - according to a report issued in the New England Journal of Medicine March 26, 2009.

In an accompanying editorial, "Prevention of Viral Sexually Transmitted Infections - Foreskin at the Forefront," two local University of Washington researchers say these new findings provide compelling new evidence on circumcision's effect on decreasing currently incurable viral sexually transmitted infections.

"These new data should prompt a major reassessment of the role of male circumcision not only in HIV prevention but also in the prevention of other sexually transmitted infections," write authors Drs. Matthew R. Golden and Judith N. Wasserheit.

"We already knew that circumcision can decrease men's HIV risk by 60%," said Golden, who is also director of the STD Control Program for Public Health - Seattle & King County. "Now we know that male circumcision reduces men's risk of herpes by 25% and of human papillomavirus by a third."

The data could be a major game changer for how health providers counsel patients and parents on circumcision.

Circumcision rates have been declining in the United States and are lowest among black and Hispanic patients -- groups with the highest rates of HIV, herpes and cervical cancer.

"These new, compelling data mean that,all providers who care for pregnant women and infants have a responsibility to assure that mothers and fathers know that circumcision could help protect their sons from the three most common and most serious viral sexually transmitted infections, all of which cannot currently be cured," said Wasserheit, who is also the vice chair of the UW Department of Global Health.

Herpes and HPV infection are extremely common, can have severe consequences and are not curable.

In the United States alone, almost one in five Americans is infected with herpes simplex virus type 2 (HSV-2).Furthermore, roughly three quarters of sexually active Americans will have at least one human papillomavirus (HPV) infection and approximately 4,500 women die every year from cervical cancer.

In many low and middle income countries, these infections are even more common and more serious. Cervical cancer is the second most common cause of cancer deaths in women worldwide.

Golden and Wasserheit say these findings should prompt professional organizations to play a leadership role in sharing with their members and the public this new information about the benefits of circumcision in preventing all three of the major viral STIs -- not only HIV, but also herpes and HPV infection.
-end-


University of Washington Health Sciences/UW Medicine

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.